
Research Square (Research Square), Journal Year: 2024, Volume and Issue: unknown
Published: Nov. 13, 2024
Language: Английский
Research Square (Research Square), Journal Year: 2024, Volume and Issue: unknown
Published: Nov. 13, 2024
Language: Английский
International Journal of Molecular Sciences, Journal Year: 2025, Volume and Issue: 26(6), P. 2384 - 2384
Published: March 7, 2025
Pancreatic adenocarcinoma (PAAD) is a fatal malignant tumor of the digestive system, and immunotherapy has currently emerged as key therapeutic approach for treating PAAD, with its efficacy closely linked to T-cell subsets immune microenvironment. However, reliable predictive markers guide clinical PAAD are not available. We analyzed single-cell RNA sequencing (scRNA-seq) data focused on from GeneExpressionOmnibus (GEO) database. Then, information Cancer Genome Atlas (TCGA) database was integrated develop validate prognostic risk model derived marker genes. Subsequently, correlation between these models effectiveness explored. Analysis scRNA-seq uncovered six subtypes 1837 differentially expressed genes (DEGs). Combining TCGA dataset, we constructed containing 16 DEGs, which can effectively predict patient survival outcomes. have found that patients in low-risk group had better outcomes, increased cell infiltration, signs activation compared those high-risk group. Additionally, analysis mutation burden showed higher rates Risk scores checkpoint gene expression drug sensitivity provide multiple targets options. Our study based genes, providing valuable insights into predicting prognosis immunotherapy.
Language: Английский
Citations
0JOR Spine, Journal Year: 2025, Volume and Issue: 8(1)
Published: March 1, 2025
ABSTRACT Background Intervertebral disc degeneration (IDD) is a major cause of cervical and lumbar diseases, significantly impacting patients' quality life. Mitochondria cell death have been implicated in IDD, but the key related genes remain unknown. Methods Differentially expressed (DEGs) between IDD control samples were identified using GSE70362. Mitochondria‐related (MRGs) programmed death‐related (PCDRGs) intersected with DEGs to find DE‐MRGs DE‐PCDRGs. Weighted gene co‐expression network analysis (WGCNA) module genes, overlap revealed candidate genes. Mendelian randomization (MR) was used determine causally linked IDD. Machine learning expression validation further refined which then build nomogram predict risk. Additionally, set enrichment (GSEA), immune infiltration, single‐cell performed. Results A total 515 224 yielding 31 Six genes—BCKDHB, BID, TNFAIP6, VRK1, CAB39L, TMTC1—showed causal relationship TMTC1 as through machine validation. developed based on these GSEA BID enriched N‐glycan biosynthesis, TNFAIP6 aminoacyl tRNA ribosomal pathways. Activated dendritic cells, CD56dim natural killer monocytes, other cells elevated strongly correlating activated cells. Key at higher levels degraded samples. Conclusion TMTC1, mitochondria offering new insights for diagnosis treatment.
Language: Английский
Citations
0Discover Oncology, Journal Year: 2025, Volume and Issue: 16(1)
Published: April 29, 2025
Language: Английский
Citations
0Scientific Reports, Journal Year: 2024, Volume and Issue: 14(1)
Published: March 26, 2024
Abstract Disulfidptosis, a newly discovered type of programmed cell death, could be mechanism death controlled by SLC7A11. This closely associated with tumor development and advancement. Nevertheless, the biological behind disulfidptosis-related genes (DRGs) in sarcoma (SARC) is uncertain. study identified three valuable ( SLC7A11, RPN1, GYS1 ) disulfidptosis developed prognostic model. The multiple databases RT-qPCR data confirmed upregulated expression DRGs SARC. TCGA internal ICGC external validation cohorts were utilized to validate predictive model capacity. Our analysis DRG riskscores revealed that low-risk group exhibited more favorable prognosis than high-risk group. Furthermore, we observed significant association between different clinical features, immune infiltration, therapeutic sensitivity, drug RNA modification regulators. In addition, two independent immunetherapy datasets tissue samples collected, validating value risk predicting immunotherapy response. Finally, SLC7A11/hsa-miR-29c-3p/LINC00511, RPN1/hsa-miR-143-3p/LINC00511 regulatory axes constructed. provided riskscore signatures predict response SARC, guiding personalized treatment decisions.
Language: Английский
Citations
3Cancer Cell International, Journal Year: 2023, Volume and Issue: 23(1)
Published: Nov. 9, 2023
Abstract Background Disulfidptosis and Ferroptosis are two novel forms of cell death. Although their mechanisms differ, research has shown that there is a relationship between the two. Investigating connection these death can further deepen our understanding development progression cancer, provide better prediction models for accurate prognosis. Methods In this study, RNA sequencing (RNA-seq) data, clinical single nucleotide polymorphism (SNP) single-cell data were obtained from public databases. We used weighted gene co-expression network analysis (WGCNA) unsupervised clustering to identify new Disulfidptosis/Ferroptosis-Related Genes (DFRG), constructed LASSO COX prognosis model was externally validated. To explore signature, pathway function performed, differences in mutation frequency high- low-risk groups studied. Importantly, we also conducted on immune checkpoint, infiltration levels resistance indicators, addition analyzing real immunotherapy data. Results have identified four optimal disulfidptosis/ferroptosis-related genes (ODFRGs) differentially expressed associated with Lung Adenocarcinoma (LUAD). These include GMPR, MCFD2, MRPL13, SALL2. Based ODFRGs, robust prognostic high-risk group showed significantly lower overall survival (OS) compared group. Furthermore, predict outcomes LUAD patients some extent.
Language: Английский
Citations
7Oncology Letters, Journal Year: 2024, Volume and Issue: 28(2)
Published: May 29, 2024
Lung adenocarcinoma (LUAD) is the most common pathological type of lung cancer, and disulfidptosis a newly discovered mechanism programmed cell death. However, effects disulfidptosis‑related lncRNAs (DR‑lncRNAs) in LUAD have yet to be fully elucidated. The aim present study was identify validate novel lncRNA‑based prognostic marker that associated with disulfidptosis. RNA‑sequencing clinical data were obtained from Cancer Genome Atlas database. Univariate Cox regression lasso algorithm analyses used DR‑lncRNAs establish model. Kaplan‑Meier curves, receiver operating characteristic principal component analysis, regression, nomograms calibration curves assess reliability Functional enrichment immune infiltration somatic mutation tumor microenvironment drug predictions applied risk Reverse transcription‑quantitative PCR subsequently performed mRNA expression levels normal cells cells. These enabled DR‑lncRNA prognosis signature constructed, consisting nine lncRNAs; U91328.1, LINC00426, MIR1915HG, TMPO‑AS1, TDRKH‑AS1, AL157895.1, AL512363.1, AC010615.2 GCC2‑AS1. This model could serve as an independent tool for patients LUAD. Numerous evaluation algorithms indicated low‑risk group may exhibit more robust active response against tumor. Moreover, dysfunction exclusion suggested immunotherapy would effective group. drug‑sensitivity results showed high‑risk sensitive treatment crizotinib, erlotinib or savolitinib. Finally, AL157895.1 found lower A549. In summary, which provided new index predict efficacy therapeutic interventions
Language: Английский
Citations
2Frontiers in Cell and Developmental Biology, Journal Year: 2023, Volume and Issue: 11
Published: Nov. 14, 2023
Background: Disulfidptosis is a newly discovered form of regulated cell death. The research on disulfidptosis and tumor progression remains unclear. Our aims to explore the relationship between disulfidptosis-related genes (DRGs) clinical outcomes papillary thyroid carcinoma (PTC), its interaction microenvironment. Methods: single-cell RNA seq data PTC was collected from GEO dataset GSE191288. We illustrated expression patterns in different cellular components cancer. LASSO analyses were performed construct associated risk model TCGA-THCA database. GO KEGG used for functional analyses. CIBERSORT ESTIMATE algorithm helped with immune infiltration estimation. qRT‒PCR flow cytometry validate hub gene samples. Results: clustered scRNA into 8 annotated types. With further DRGs based scoring analyses, we found endothelial cells exhibited most disulfidptosis. A 4-gene established pattern related subset. showed good independent prognostic value both training validation dataset. Functional enrichment genomic feature analysis significant correlation signature. results estimation higher scores immuno-suppressive microenvironment PTC. Conclusion: study role signature regulation survival patients. (including SNAI1, STC1, PKHD1L1 ANKRD37) built basis cells. significance outcome validated robustly.
Language: Английский
Citations
4Asian Journal of Surgery, Journal Year: 2024, Volume and Issue: 47(8), P. 3464 - 3477
Published: March 11, 2024
In recent times, disulfidptosis, an intricate form of cellular demise, has garnered attention due to its impact on prognosis, tumor progression and treatment response. Nevertheless, the exact significance disulfidptosis-related genes (DisRGs) in glioblastoma (GBM) remains enigmatic. The GEO TCGA databases provided transcriptional clinically relevant data samples, while GTEx database healthy tissues. Disulfidptosis-related were procured from previous scholarly investigations. expression profile DisRGs was initially scrutinized among patients diagnosed with GBM, subsequent which their prognostic value explored. Through consensus clustering, we constructed DisRGs-related clusters gene subtypes. Our results established that DisRG-related had differentially expressed genes, resulting a DisulfidptosisScore model, positive value. differential 24 between GBM samples acquired. cluster analysis, two distinct disulfidptosis subtypes, namely DisRGcluster A B, identified. Then, model including 4 characteristic constructed.Notably, assigned lower score demonstrated considerably longer overall survival (OS) compared those higher score. We have effectively devised associated presenting autonomous predictions for GBM. These findings serve as valuable addition current comprehension offer fresh theoretical substantiation development enhanced strategies.
Language: Английский
Citations
1Heliyon, Journal Year: 2024, Volume and Issue: 10(15), P. e35305 - e35305
Published: July 31, 2024
Mitophagy is the selective degradation of mitochondria by autophagy. It becomes increasingly clear that mitophagy pathways are important for cancer cells to adapt their high-energy needs. However, which genes associated with could be used prognosis unknown.
Language: Английский
Citations
1Current Issues in Molecular Biology, Journal Year: 2023, Volume and Issue: 45(12), P. 9450 - 9470
Published: Nov. 24, 2023
Disulfidptosis is a newly discovered cellular programmed cell death mode. Presently, considerable number of genes related to disulfidptosis remain undiscovered, and its significance in hepatocellular carcinoma remains unrevealed. We have developed powerful analytical method called RF-GSEA for identifying potential associated with disulfidptosis. This draws inspiration from gene regulation networks graph theory, it implemented through combination random forest regression model Gene Set Enrichment Analysis. Subsequently, validate the practical application value this method, we applied carcinoma. Based on disulfidptosis-related signature. Lastly, looked into how signature connected HCC prognosis, tumor microenvironment, effectiveness immunotherapy, sensitivity chemotherapy drugs. The identified total 220 genes, which 7 were selected construct high-disulfidptosis-related score group had worse prognosis compared low-disulfidptosis-related showed lower infiltration levels immune-promoting cells. higher likelihood benefiting immunotherapy group. tool genes. effectively predicts response, drug sensitivity.
Language: Английский
Citations
2